elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q35674875-3E258CD9-47F4-4BB1-AB2E-A5659DCAB28E
Q35674875-3E258CD9-47F4-4BB1-AB2E-A5659DCAB28E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35674875-3E258CD9-47F4-4BB1-AB2E-A5659DCAB28E
Phase I Trial of Arginine Deprivation Therapy with ADI-PEG 20 Plus Docetaxel in Patients with Advanced Malignant Solid Tumors.
P2860
Q35674875-3E258CD9-47F4-4BB1-AB2E-A5659DCAB28E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35674875-3E258CD9-47F4-4BB1-AB2E-A5659DCAB28E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
51622c216d598bf6255068b4675d8f501f698f4f
P2860
Arginine deprivation as a targeted therapy for cancer.